Abstract:Background Mood disorders, including major depressive disorder (MDD) and bipolar disorder (BD), are characterized by severe mood disturbances and have collectively caused a significant burden of diseases. However, diagnosing and distinguishing between the two disorders can be challenging due to the variability of symptoms. Growing evidence in the gut-brain axis has shed light on the connection between gut microbiota, their functions, and the central nervous system, especially for mood disorders. The present study aimed to identify specific microbiota markers associated with MDD and BD in a sample of Han Chinese individuals. Methods We recruited 479 subjects (197 MDD, 158 BD, and 124 healthy controls) and obtained their basic demographic characteristics, dietary factors, and symptom severity data through questionnaires. We performed 16S rRNA sequencing to obtain their microbiota profiles. We compared the microbial diversity between groups by alpha and beta diversity indices. We used multivariate regression analysis to identify differential taxa that could serve as potential biomarkers after adjusting for batch effect, age, BMI, and sex. The correlation between the selected taxa within each group was visualized using a direct force graph, and the correlation between taxa and other variables was assessed through heatmaps. Functional analysis was also performed to explore differences between groups. Furthermore, a co-occurrence network analysis was conducted to investigate the connections between the selected taxa and the functional pathways. Results Patients with MDD or BD exhibited lower alpha diversity and significant beta diversity (p < 0.01) compared to healthy controls across all diversity indices. The abundance of Bacteroidota and Desulfobacterota was reduced in the patients, while Firmicutes were more abundant. At the genus level, we found six taxa, including Bilophila, that were reported in both MDD and BD groups, eight taxa, including Bacteroides, that were specific to MDD patients, and three taxa, including Coprococcus, that were specific to BD patients. Among all groups, Bacteroides had the strongest associations within the correlation network. The two most significant pathways were both related to energy production. Additionally, we found that two important depression-related ways, purine biosynthesis and pyrimidine biosynthesis, were reduced in MDD patients. Bacteroides were associated with energy production pathways and gluconeogenesis in MDD patients, while Coprococcus showed the most associations with identified pathways in BD patients. Discussion Patients with mood disorders showed reduced microbial diversity and distinct microbial composition compared to healthy individuals, supporting previous findings suggesting gut dysbiosis in mood disorder patients. The identified microbiota taxa align with previous studies and could potentially serve as discriminative biomarkers for patients with mood disorders. These specific taxa may also participate in mood disorder-related functional pathways, such as purine and pyrimidine biosynthesis.

Characteristics of gut microbiota and metabolic phenotype in patients with major depressive disorder based on multi-omics analysis

Characteristics of the Gut Microbiota in Bipolar Depressive Disorder Patients with Distinct Weight.

Gut Microbial Signatures Can Discriminate Unipolar from Bipolar Depression

Integrated multi-omics analysis reveals gut microbiota dysbiosis and systemic disturbance in major depressive disorder

Microbiota Alters and Its Correlation with Molecular Regulation Underlying Depression in PCOS Patients

Gut microbiota and inflammatory factor characteristics in major depressive disorder patients with anorexia

Variations in Gut Microbiota and Fecal Metabolic Phenotype Associated with Depression by 16S Rrna Gene Sequencing and LC/MS-based Metabolomics.

A pilot exploration of multi-omics research of gut microbiome in major depressive disorders

Comparative metaproteomics analysis shows altered fecal microbiota signatures in patients with major depressive disorder.

Taxonomic and Metabolic Signatures of Gut Microbiota for Assessing the Severity of Depression and Anxiety in Major Depressive Disorder Patients.

Deciphering the Gut Microbiome's Influence on Depression: A Community-Level Constraint-Based Metabolic modelling Approach

Alterations of the Composition and Neurometabolic Profile of Human Gut Microbiota in Major Depressive Disorder

Interplay of Metabolome and Gut Microbiome in Individuals With Major Depressive Disorder vs Control Individuals.

Multiomics Study of Gut Bacteria and Host Metabolism in Irritable Bowel Syndrome and Depression Patients

Gut Microbiota-Derived Inflammation-Related Serum Metabolites as Potential Biomarkers for Major Depressive Disorder

Plasma Metabolomics Profiling of Metabolic Pathways Affected by Major Depressive Disorder

Comparative analysis of gut microbiota and fecal metabolome features among multiple depressive animal models

48. THE POTENTIAL MICROBIOTA BIOMARKER AND FUNCTIONAL CHARACTERISTICS BETWEEN PATIENTS WITH MAJOR DEPRESSIVE DISORDER, BIPOLAR DISORDER, AND HEALTHY CONTROLS

Gut microbiota and its metabolites in depression: from pathogenesis to treatment

Relationships between the gut microbiome and brain functional alterations in first-episode, drug-naïve patients with major depressive disorder

Gut Microbiota Metabolites in Major Depressive Disorder—Deep Insights into Their Pathophysiological Role and Potential Translational Applications